Popular New
- Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms13 daysScheperjans, F(ilip)*Read
- Diagnostic value of micrographia in Parkinson's disease: a study with [<sup>123</sup>I]FP-CIT SPECT36 daysScheperjans, F(ilip)*Read
- Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson's disease82 daysScheperjans, F(ilip)*Read
- Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease107 daysScheperjans, F(ilip)*Read
- Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses189 daysScheperjans, F(ilip)*Read
- Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease199 daysScheperjans, F(ilip)*Read
- Gut microbiome alpha-diversity is not a marker of Parkinson's disease and multiple sclerosis249 daysScheperjans, F(ilip)*Read
- Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials301 daysScheperjans, F(ilip)*Read
- Diagnostic accuracy of glabellar tap sign for Parkinson's disease338 daysScheperjans, F(ilip)*Read
- Validation of the Finnish Version of the Unified Dyskinesia Rating Scale354 daysScheperjans, F(ilip)*Read
- Gut microbiome signatures of risk and prodromal markers of Parkinson's disease407 daysScheperjans, F(ilip)*Read
- Irritable Bowel Syndrome and Risk of Parkinson's Disease in Finland: A Nationwide Registry-Based Cohort Study432 daysScheperjans, F(ilip)*Read
- Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease432 daysScheperjans, F(ilip)*Read
- Gut microbiota composition is associated with narcolepsy type 1432 daysScheperjans, F(ilip)*Read
- Lack of Accredited Clinical Training in Movement Disorders in Europe, Egypt, and Tunisia432 daysScheperjans, F(ilip)*Read
- Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease432 daysScheperjans, F(ilip)*Read
- Antibiotic exposure and risk of Parkinson's disease in Finland: A nationwide case-control study432 daysScheperjans, F(ilip)*Read
- Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review432 daysScheperjans, F(ilip)*Read
- Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [<sup>123</sup>I]FP-CIT SPECT432 daysScheperjans, F(ilip)*Read
- Deep brain stimulation for dystonia in Finland during 2007-2016432 daysScheperjans, F(ilip)*Read
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression432 daysScheperjans, F(ilip)*Read
- Comorbidity and retirement in cervical dystonia432 daysScheperjans, F(ilip)*Read
- Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT432 daysScheperjans, F(ilip)*Read
- The Gut and Parkinson's Disease: Hype or Hope?432 daysScheperjans, F(ilip)*Read
- The prevalence of adult-onset isolated dystonia in Finland 2007-2016432 daysScheperjans, F(ilip)*Read
- Motor outcome and electrode location in deep brain stimulation in Parkinson's disease432 daysScheperjans, F(ilip)*Read
- The prodromal microbiome432 daysScheperjans, F(ilip)*Read
- More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota432 daysScheperjans, F(ilip)*Read
- Emergency computed tomography in patients with first seizure432 daysScheperjans, F(ilip)*Read
- Oral and nasal microbiota in Parkinson's disease432 daysScheperjans, F(ilip)*Read
- Intracerebral hemorrhage location and outcome among INTERACT2 participants432 daysScheperjans, F(ilip)*Read
- Gut microbiota, 1013 new pieces in the Parkinson's disease puzzle432 daysScheperjans, F(ilip)*Read
- Can microbiota research change our understanding of neurodegenerative diseases?432 daysScheperjans, F(ilip)*Read
- Prognostic Significance of Hyponatremia in Acute Intracerebral Hemorrhage: Pooled Analysis of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies432 daysScheperjans, F(ilip)*Read
- Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage432 daysScheperjans, F(ilip)*Read
- Low Ambient Temperature and Intracerebral Hemorrhage: The INTERACT2 Study432 daysScheperjans, F(ilip)*Read
- Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage432 daysScheperjans, F(ilip)*Read
- Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial432 daysScheperjans, F(ilip)*Read
- Reply to letter to the editor by Assoc. Prof. Yusuf Ozgur Cakmak, MD, PhD432 daysScheperjans, F(ilip)*Read
- Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?432 daysScheperjans, F(ilip)*Read
- Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2432 daysScheperjans, F(ilip)*Read
- Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2432 daysScheperjans, F(ilip)*Read
- Gut microbiota are related to Parkinson's disease and clinical phenotype432 daysScheperjans, F(ilip)*Read
- Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage432 daysScheperjans, F(ilip)*Read
- IV Thrombolysis-Bridging and Endovascular Treatment for Occlusive Internal Carotid Artery Dissection with Tandem Occlusion432 daysScheperjans, F(ilip)*Read
- Intravenous thrombolysis in ischemic stroke patients with isolated homonymous hemianopia432 daysScheperjans, F(ilip)*Read
- Hypoperfusion of an entire cerebral hemisphere - stroke or postictal deficit?432 daysScheperjans, F(ilip)*Read
- The human inferior parietal lobule in stereotaxic space432 daysScheperjans, F(ilip)*Read
- Probabilistic maps, morphometry, and variability of cytoarchitectonic areas in the human superior parietal cortex432 daysScheperjans, F(ilip)*Read
- Human superior parietal lobule is involved in somatic perception of bimanual interaction with an external object432 daysScheperjans, F(ilip)*Read

Impact Factor: 3.146
SJR: 1.602
JUFO: 0.667
Articles: 10
Terkko Factor: 18.3 (√IF*SJR*JUFO * Num)
Based on articles published in the last 12 months.
Profile on PlumX
- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology